Sign in
4

Changes in Ownership

KIORA PHARMACEUTICALS INC Filed Acc 0001104659-22-111246

Chief Development Officer acquired 10,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Daniels Eric Joseph · Chief Development Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2022-10-21 Grant or award : show line 1 in the form +10,000 10,238 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-10-21 Grant or award : show line 2 in the form Stock Option (right to buy) +15,000 15,000 D
Loading xslF345X03/tm2228925-3_4seq1.xml…